Aflibercept Drug Information
Aflibercept (EyleaTM) is a drug prescribed to treat a type of age-related eye disease called neovascular "wet" macular degeneration. This medicine is available as an injection that is given directly into the eye by a healthcare provider every month for 12 weeks. Thereafter, it is given once every two months.
Although it is generally well tolerated, this drug is not suitable for everyone. Before receiving aflibercept, make sure your healthcare provider has up-to-date information on your medical history and a list of your current medications. In particular, make sure to let your healthcare provider know if you have an eye infection or a history of a blood clot or stroke. Possible side effects include eye pain, cataracts, and blood spots on the white part of the eye.
(Click Aflibercept for more information on receiving this drug. This Web selection takes a closer look at how the medication works, dosing instructions, and safety precautions to be aware of while using it.)